Detail akcie CryoPort online

Business Summary: Cryoport, Inc. is a provider of integrated, temperature-controlled supply chain solutions for the life sciences. The Company operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.
Financial Summary: BRIEF: For the six months ended 30 June 2026, CryoPort Inc revenues increased 12% to $96.8M. Net loss applicable to common stockholders excluding extraordinary items decreased 5% to $21.7M. Revenues reflect Life Sciences Services segment increase of 13% to $55.7M, Life Sciences Products segment increase of 10% to $41.1M, Americas segment increase of 10% to $71.8M, Europe & Middle East & Africa (EMEA) segment increase of 49% to $17M.